Date: l3108/2018

To Vivimed
BSB Limired National Stock Exchange oflndia Ltd.
P.J.Towers, Dalal Street, Exchange Plaza,plot no. C/1, G Block,
Mumbai - 400001 Bandra-Kurla Complex, Bandra (E)
BSE - Code t 532660 Mumbai - 400 051
NSE- Symbol: VI\aIMEDLAB

Dear Sir/Madam

Sub: Outcome of the Meeting of the Board of Directors of the Company _ reg.

The Board of Directors of the Company at its meeting held on August 13,201g
inter alia, have
approved / resolved/ taken note ofthe following:

l. Pursuant to Regulation 33 ofthe Seclrities and Exchange Board of India (Listing

Obligatrons
and Disclosure Requirements) Regulations, 2015 considered and approvei ttre s]uUmisiion
of
the Un-audited Financial Results (Standalone & Consolidated) for ihe quarter ended
lune:0,
2018 attached herewith;

2. Auditors's Limited Review Report on the Un-audited Financial statements of the company
for the quarter ended June 30, 2018.

3. Directors Report for the financial year ended 3l .03.201g together with annexure thereto.

4. convening ofAnnual General Meeting (AGM) on 27.09.20rg and Notice of AGM-

5. Fixed Book closure dates from Saturday, September 22, 201g to Thursday,
September 27,
2018 (both days inclusive) for the purpose of AGM and cut
-off dateTRecord
determining the names of the erigible Members for equity dividend is September
date tbr
21, 201C.

6. Has accepted the resignation of Dr.Venkateswarulu Peesapati from the Board of Directors of
the Company

7. The Board leamt about the sad demise of Sri.Venkata Ratnam paluri, Director
of the
company on July 01, 2018. The Board expressed its condorences *a uppr""iut"a-una
record the valuable services rendered by Sri.venkata Ratnam paruri iut on
during his tenure of
directorship in the Company.

8. Reconstituted various Committees ofBoard.

Th^e^dividend, if approved by the Members at the ensuing AGM, will be paid on or after october
l, 2018 and on or before October 26, 201g.

You are requested to take note ofthe above.

Yours faithfu lly

For

SANTOSH AR
MANA DIRECTOR
Vivimed Labs Limited 969iste "d 0ftrcel
clN: 10241 1 KA1 988PrC009465 Corporate office:
#78lA, Kothar Industrial Area, North End, Road No.2
Brdar, Karnataka 585 403, India. Banjara H itls, Hyderabad,
T +91 {0j 8482 232A45, F +91 lAl8482-232/,36 Telangana - 500 034, India.
Emait: coniactAvivimedtabs.com I www.vivimedLabs.com T +91t0l 40 6608-6608, F +91[0] 40-6608-6699
 UNAWITED CONSOUDAIED IIN?{NC!/11 RESTILTS EOR TEE QUARTER ENDED 30.06.2f/.5

Iu9nE Fnn Opaalions

Re.,enue fton opentiots

Total nunue fton oFntions

Total Retenuz (1+2)

Crst ol crnsunvd
"ateiat 15,02s.35 13,2U.27
Purclass ol Stoc*- i - Tnde
Ctergesir inae ones oJfnislbd s@ds wo* in prcwss and stnckin_Tladz
(742.70) (2,339.01)
Entpwc Betgft Expe sas
5,7985i 5,830.35
1,928.00 1,636.63
Depreciatiot and Anofisnon Expenes
1,586.73 1,383.95
8,892.53 8,490,94

Ptoft b.hft tnx (3-4)

Proftht ttg pdbd /year qorc rc -co,ttaorjinsirbrcst (5-6)

No]l-co tro ingtuvrc.r
Ptoft lot ttg peiot/ leat (7-8)
O the rn ry rcl Ensity ifttm e
Iums st" uill not k n.k"ifrpd to ptofr or toss, wt ol t ,
ttlnls tt@tui be n.lrsnfedto proft ol105',Etolt r
Total otlzt cofttt l1e'iae incarg
Na -cottolkfg iterest
Other conprelE$i1E i,@ne aftnbutabb to slarehotdrrc(10+11)
Tott! @ Wlensiw incttre dttnlutabte to:
Shareltulderc of the Conryany
N o t t -co n to I li,tg ite rc{
Totll Co p4lvnsiw i can\

per stuE (IEhle *bao itur! Len s) (ofR 2J- eoct, (nor a nustivd)

xft,i7l"-;;if'',di|edFi|nti'lResuItshtt|EQMttetefd'dIu|Ej0.06.2018hawbeenfnieIuedandr@n'fmdadbyth?AuditColfn'itt?ea'laPp|dwtkBu

:;;#::i*#;i;::''#:i:it''y,mr#,l,::",.,*nceuithAcc'untin8sta|d'rd.21is9uedwIcA.I.a'mlidatedResuItsate@nbirdnumbefsofvioinEdIabsLimit2dandits
(iii)viUinedHoldi''gsLini|edg,1di|sst|pdu'||subsidia/i's.9.v'1',y1k"ri,"l"Li,;;;-i;;;:;;;:;i:';:;;;''#i";:;;a:;#,3'"'if,i;,,]:;{J#j##;#.
ited(iii)viUinedHot|ti''gsLinit"dg|tdi|ssbrdou1s:ilH'::i::{:r#:,y"y::*r,j'i!i'":!^':i:!!yyr,.y:i:;;;;;;;;:;;;;,;;;;|;;;;
'ff'!;f,)"71'p^" "no4ludited,uKtr(i)uq"inu"'i*s.t.*c.v.tiii*itniiit*i,"*ttaatso",*ct"*t*iL;;;;;;;;i)-*",*r,aono,o,nnn"ua",*,,qe

!;,!;;,'u',,*u'"*a,'oAs108opennre8rnt'thza'nw|yha'wifnrfn*gnents||speciaIitychemicaL'rand''P]amf'|a'occotdi'l8Irconsirdunft|b

nutlibe$ of preoious pedod / yur hnc beet leg/ouped, uhnav Mcesstry.

Date :13.08.2018
B
338
.r.i\i s NF.tt\ t\
..t ,,1 N
338 Rs$$ N 'ri
ni .c
s$$ €' (o'd d .-€"
e
.:
t'o N' ot
E'3.t $ qr'
'rt
E
E
!* \SH
s
N t'
t
5

t'idrl
qAo!
trl (o' q'
N
N

N
R3\3
tdctN6i
.i $ ro'
^i
{
N
.ft
cllo
ol vl
q(E'
N
lrr
('t
$
N 6i
N'kl
q)ct
^i -i

6R
tus)F) >/;
*
c.l
ql
sN8
$$oo'
I
co'
(\
\fniN(Ij
-i nl .t
e
\O(o
-iv
dAtci

R
',i
qt oi vt
v;rg
\--J\
'//
7
E or
!i q "t rn .t
qo)
a riGri tt R
9' 3B8R ct
(
qi .j ct .i r.i
o $.t tn' tt *i \i tn' -t nl FIN
(JO ot oo' .l
o
nt c.l -i
l-E
l\:- I
=
Fe Flt t'
d's o Et<E "
.9
h.5 x]
geip
E
o-
E+s il ilBS" ilegr
EE
xl rl
!R==8"
$ H! E g HI*fFE
El t*
ip
.El
Ftt = .p
s bt $ti
HI
ElPi6 s alr i'; )!a
ri .9
E$t$f rl iIEESE 0f a ,:tr{
Fli
I "'j "; {'t .:
So
$$
$EE.R$ii'l Ele
HE
.at
"islej{iFil !18$t€ H
_at.r,
h |
,
d{i ct {i $A
 lncotne Erottt Opentiols
Rnvnue Irom oryntions

Total @alue Irorn operations

Totol Leoefite (7+2)

Cost ol,nabtiol @nsu ed 3,1 .05 2.552.n 11,494n

Plrcfues ol Sto.k- in- Tradc
Changes in inl'entoies offnidad Soods tr,erk in progess and sto&-in-'hailz o,207.44) (119.08) (2,854.63)
EtlpIoW Be eft E pen*s 693.8i 3,$8.6i
1,214 5.180.22
Depleciat io" and Ano,tisstion hpen*s 440.08 u7.07 1,814.i6
Other Eqenss 2,031.05 1,677.19 6,4,3.01
Total E penses
Profit behre taa (34)

Cuftent Taxee
DeftrcdTftes

Ptofit lor peiod/Y.u (s-6)

'e
Oth Ctmplehznshn incme
Items thAt loill not be recbssifed to ptoft or loss, tvt of tM
Itams that uill
rccltssiftd to ploft ot bss, net of tar
be
Total othct conptehen*ie incoie
Total conprche sioe in.ot p O+8)

equity
tgs per Sharc (belore E trtordinLry ltelis) (of Rs4- eacL)

Th2abovestanflonrAudit?dFinancig|Resu|t3k|theQ1a|teroYeatefd2d]ne30,2018ha,ebeenraieU?nandrcofed2dbytfAuditcommitteeandw|dwf
itf2etif8h'ldon1j.08.2u8.ThcFinacialrg/ItsafPrPNeilin4ccoibnceuiththzIfdia1Ac@uti,18st4ntas0ndAs)asP;esfdunf|
(lndia Accout1ting Stondgrds)Rulc'2'1s (as dmrndtd)

IlinewithFroukionsoIIndAs.I08owntin8segnents,th2ConPM!h$PnfanIyh.'og8nets''s?eci'litydEfiaIsrand"Phann'rgnd'c@rdin81y

n nberc ol preuious peliod / fen hne tuen rcgouped, whereuet necessary.

o
DaE : 13.08.2U8 f
 aaoa s o
s NNvic;
ooo s .ic;
a
tsNB 338S
lri
$ Rg qi
r$a
o tq ra od qt d nl\id'd "l
qi oo'
'd
.ri
t\ ! 338 o
s coN
o CJ
8Nn vi Ct qt qt \r rYi ctG N qt ni
ffiR
w
(o or l.at ro co
.l$6 d Noi d N ..i
ci
tr Nrn
$[
e

ro
o
s !
S

e,

(o\to
N.isi
bNR
(\i$(o'
I
o\
or
t\
88R3
oi *i .i ti
R&ES
Ft *t

coci
od6
-t
\tYi
ot

qt
oi .iq;
rto
ul
*i
od
^14 : 'i
=E t' RN3
doiqi
!n
qt
\$$R qr
rt no ro
3i
r( !,
s)
i=
! Rqg
-l$!t $$$$ oi NFi
R8
qt \t ui
o< I
st
E h's
*t
>*F
S,"
>-=
-o
z^q
s
\
s E
* \E
9q,
{
= -
E
IF ot, -rt 3: S
E i: t. \! E
ol
liF-
P
dt' d*"
ss$ $F
-=ar at'
lEE
eFS* dl :t;
SFE
ES€s$
sP
sl

el Plr
FI 8t
ol
ct'
r

iE s
gE€F n t* EE* $l
Fl
EI
t vs
EP
al :s s;
{ .:e
aiQ
3.e
!oo
"iH
HS=EEF EI c$t! ;$sE
\l :
gQ5 |rl r So c:: gH
FSsF:-sl rlo1 I Sr :
tri
l$-gSE;^' El J
!
ili ,i3;;es BI Ep' i;::
lsir"SE$l :ln i t .a*
ctd 3,;
$ cid SE
 P C N & ASSOCIATES Tel. : (91-40) 2311 9499
CHARTERED ACCOUNTANTS E-mail : pcnassociates@yahoo.com
Plot No. 12, "N Heights"
Ground Floor, Software Layout Unit
Cyberabad, Hyderabad - 500 081.

LIMITED REVIEW REPORT-CONSOLIDATED FINANCIAL RESULTS

To
The Board of Directors,
M/s. Vivimed Labs Limited,
Hyderabad

Limited Review Report for the quarter ended 30th June. 2018

1. We have reviewed the accompanying statement of unaudited Consolidated financial results

("the Statement") of M/s. Vivimed Labs Limited Group comprising M/s. Vivimed Labs
Limited ("the Company") and its subsidiaries (together referred to as 'the group'), for the
quarter ended 30th June, 2018, being submitted by the Company pursuant to the
requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure
requirements) Regulations, 2015, read with SEBI Circular No. CIR/CFD/FAC/62/2016
dated July 5th 2016.

2. The preparation of the statement in accordance with the recognition and measurement
principles laid down in Indian Accounting Standard 34, Interim Financial Reporting (Ind AS
34) prescribed under Section 133 of the Companies Act, 2013 read with Rule 3 of
Companies (Indian Accounting Standards) Rules, 2015 read with SEBI Circular No.
CIR/CFD/FAC/62/2016 dated July 5th 2016 is the responsibility of the Company's
Management and has been approved by the Board of Directors in their meeting held on 13th
August 2018. Our responsibility is to issue a report on the statement based on our review.

3. We conducted our review in accordance with the Standard on Review Engagement (SRE)
2410, Review of interim financial information performed by the independent auditor of the
entity issued by the Institute of Chartered Accountants of India. This standard requires that
we plan and perform the review to obtain moderate assurance as to whether the financial
statements are free of material misstatement. A review is limited primarily to inquiries of
nel and analytical procedures applied to financial data and thus provide
 P C N & ASSOCIATES : (91 -40) 2311 9499
- CHARTERED
CA ACCOUNTANTS
Plot No. 12, "N Heights"
Ground Floor, Software Layout Unit
E-mail : pcnassociates@yahoo.com

Cyberabad, Hyderabad - 500 081.

less assurance than an audit. We have not performed an audit and accordingly, we do not
express an audit opinion.

4. Based on our review conducted as above, nothing has come to our attention that causes us
to believe that the accompanying statement of unaudited Consolidated financial results
prepared in accordance with applicable accounting standards and other recognized
accounting practices and policies has not disclosed the information required to be disclosed
in terms of Regulation 33 of the SEBI ( Listing obligations and Disclosure requirements)
Regulations, 2015 and SEBI circular dated 05th July 2016 including the manner in which it is
to be disclosed, or that it contains any material misstatement.

For P C N & Associates.,

Chartered Accountants.,
FRN: 016016S

ri ?. 41,
(...) ro \
Chandra a, Hyderabad cr),
* ERN:016016S * 11
0
Partner
.6red Acc
0w
M.No. 227849

Place: Hyderabad
Date: 13th August 2018
 P C N & ASSOCIATES Tel. : (91-40) 2311 9499
CHARTERED ACCOUNTANTS E-mail : pcnassociates@yahoo.com
Plot No. 12, "N Heights"
Ground Floor, Software Layout Unit
Cyberabad, Hyderabad - 500 081.

To

The Board of Directors

Vivimed Labs Limited
Hyderabad

Limited Review Report for the quarter ended 30th June, 2018

1. We have reviewed the accompanying statement of unaudited Standalone financial results of

M/s. Vivimed Labs Limited for the quarter ended 30th June, 2018, being submitted by the
Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and
Disclosure requirements) Regulations, 2015.

2. This statement is the responsibility of the Company's Management and has been approved by
the Board of Directors/ committee of Board of Directors in their meeting held on 13th August,
2018. Our responsibility is to issue a report on these financial statements based on our review.

3. We conducted our review in accordance with the Standard on Review Engagement (SRE)
2410, Review of interim financial information performed by the independent auditor of the entity
issued by the Institute of Chartered Accountants of India. This standard requires that we plan
and perform the review to obtain moderate assurance as to whether the financial statements
are free of material misstatement. A review is limited primarily to inquiries of company
personnel and analytical procedures applied to financial data and thus provide less assurance
than an audit. We have not performed an audit and accordingly, we do not express an audit
opinion.

4. Based on our review conducted as above, nothing has come to our attention that causes us to
believe that the accompanying statement of unaudited Standalone financial results prepared
in accordance with applicable Ind AS and other recognized accounting practices and policies
has not disclosed the information required to be disclosed in terms of Regulation 33 of the
SEBI (Listing obligations and Disclosure requirements) Regulations, 2015 and SEBI circular
dated 05th July 2016 including the manner in which it is to be disclosed, or that it contains any
material misstatement.

For P C N & Associates

Chartered Accountants
FRN: 01601

fl
Chandr. Ba 9

Partner
M.No. 227849

Place: Hyderabad
Date: 13th August 2018